SESSION I - 12th International Conference "Complex treatment of plasma cell dyscrasias in 2024"

OPENING THE CONFERENCE
prof. Maciej Małecki and prof. ARTUR JURCZYSZYN
Jagiellonian University, Kraków, Poland

00:08:43 SESSION I Chairman: prof. Wiesław W. Jędrzejczak, prof. Piotr Rzepecki, dr Michał Bator

00:08:58 prof. SURBHI SIDANA
Stanford University, USA
“CAR-T cell therapy in multiple myeloma: current limitations and potential strategies”

00:47:34 prof. VAISHALI SANCHOROWALA
Boston Medical Center, USA
“Advances in systemic AL amyloidosis”

01:19:11 prof. AARON CIECHANOVER
Technion-Israel Institute of Technology, Faculty of Medicine,
Haifa, Israel
“The Ubiquitine Proteolitic System: From the Bench to the Bedside”

01:46:01 prof. DAVID H. VESOLE
Myeloma Division, Myeloma Research
John Theurer Cancer Center, Hackensack Meridian School of Medicine, Georgetown University, USA
“T-cell redirecting antibody in patients with relapsed or refractory multiple myeloma”


September 6–7, 2024
Jagiellonian University Medical College Kraków, św. Anny 12